High dose metoclopramide as an antiemetic for patients receiving chemotherapy with cis-platinum
Daniels, M.; Belt, R.J.
Oncology Nursing Forum 9(3): 20-22
1982
ISSN/ISBN: 0190-535X PMID: 6921788 Document Number: 191540
Document emailed within 1 workday
Related Documents
Abad-Esteve, A.; Rosell, R.; Moreno, I.; Monrás, P.; Fernández, C.; Serichol, M.; Clotet, M.; Ribas Mundó, M. 1986: Evaluation of an antiemetic regimen with a high-dose metoclopramide, dexamethasone and diphenhydramine combination in chemotherapy regimens with cisplatin Medicina Clinica 87(19): 796-798Chevallier, B. 1990: Efficacy and safety of granisetron compared with high-dose metoclopramide plus dexamethasone in patients receiving high-dose cisplatin in a single-blind study. the Granisetron Study Group European Journal of Cancer 26(Suppl 1): S33-S36
Martín Jiménez, M.; González Larriba, J.L.; Sangro, B.; Díaz-Rubio, E. 1986: Antiemetic inefficacy of high intravenous doses of metoclopramide by short-term infusion in vomiting induced by antineoplastic chemotherapy Medicina Clinica 87(5): 215-216
Bhatia, A.; Tripathi, K.D.; Sharma, M. 2003: Comparison of ondansetron with metoclopramide in prevention of acute emesis associated with low dose & high dose cisplatin chemotherapy Indian Journal of Medical Research 118: 33-41
Scarfone, G.; Villa, A.; Parazzini, F.; Sciatta, C.; Polverino, G.; Bolis, G. 1999: A phase I-II trial of high-dose ifosfamide in patients with ovarian cancer refractory or resistant to platinum and/or paclitaxel-containing chemotherapy Tumori 85(4): 217-219
Pradermdee, P.; Manusirivithaya, S.; Tangjitgamol, S.; Thavaramara, T.; Sukwattana, P. 2006: Antiemetic effect of ondansetron and dexamethasone in gynecologic malignant patients receiving chemotherapy Journal of the Medical Association of Thailand 89(Suppl 4): S29-S36
Hatsuyama, T.; Umehara, K.; Wakamoto, A.; Sato, H. 2015: Study on the Antiemetic Effects of Aprepitant in Patients with Lung Cancer Receiving Chemotherapy with Carboplatin Gan to Kagaku Ryoho. Cancer and ChemoTherapy 42(6): 725-729
Chen, T.L.; Passos-Coelho, J.L.; Noe, D.A.; Kennedy, M.J.; Black, K.C.; Colvin, O.M.; Grochow, L.B. 1995: Nonlinear pharmacokinetics of cyclophosphamide in patients with metastatic breast cancer receiving high-dose chemotherapy followed by autologous bone marrow transplantation Cancer Research 55(4): 810-816
Roila, F.; Tonato, M.; Basurto, C.; Canaletti, R.; Morsia, D.; Passalacqua, R.; DiCostanzo, F.; Donati, D.; Colombo, N.; Ballatori, E. 1985: Antiemetic activity of two different high doses of metoclopramide in cisplatin-treated cancer patients: a randomized double-blind trial of the Italian Oncology Group for Clinical Research Cancer Treatment Reports 69(12): 1353-1357
Maneechawakajorn, J.; Suksuperm, J. 2014: Quality of life in advanced non-small cell lung cancer receiving chemotherapy of platinum combination in old versus new standard chemotherapy regimen Journal of the Medical Association of Thailand 97(Suppl 11): S69-S75
Hellenbrecht, D.; Saller, R. 1986: Dose-response relationships of the objective and subjective antiemetic effects and of different side effects of metoclopramide against cisplatin induced emesis Arzneimittel-Forschung 36(12): 1845-1849
Numbenjapon, T.; Sriswasdi, C.; Mongkonsritragoon, W.; Leelasiri, A.; Prayoonwiwat, W. 2002: Comparative study of low-dose oral granisetron plus dexamethasone and high-dose metoclopramide plus dexamethasone in prevention of nausea and vomiting induced by CHOP-therapy in young patients with non-Hodgkin's lymphoma Journal of the Medical Association of Thailand 85(11): 1156-1163
Taguchi, K.; Iihara, H.; Ishihara, M.; Komori, Y.; Tanizawa, K.; Matsuura, K.; Itoh, Y. 2009: Comparison of antiemetic efficacy between single and repeated treatments with a 5-HT3 receptor antagonist in breast cancer patients with high-risk emetogenic chemotherapy Anticancer Research 29(5): 1721-1725
Perez, E.A.; Lembersky, B.; Kaywin, P.; Kalman, L.; Yocom, K.; Friedman, C. 1998: Comparable safety and antiemetic efficacy of a brief (30-second bolus) intravenous granisetron infusion and a standard (15-minute) intravenous ondansetron infusion in breast cancer patients receiving moderately emetogenic chemotherapy Cancer Journal from Scientific American 4(1): 52-58
Hesketh, P.J.; Crews, J.R.; Cohen, R.; Blackburn, L.M.; Friedman, C.J. 2000: Antiemetic efficacy of single-dose oral granisetron (1 mg vs 2 mg) with moderately emetogenic chemotherapy Cancer Journal 6(3): 157-161
Soukop, M. 1990: A comparison of two dose levels of granisetron in patients receiving high-dose cisplatin. the Granisetron Study Group European Journal of Cancer 26(Suppl 1): S15-S19
Osoba, D.; Murray, N.; Gelmon, K.; Karsai, H.; Knowling, M.; Shah, A.; McLaughlin, M.; Fetherstonhaugh, E.; Page, R.; Bowman, C.A. 1994: Quality of life, appetite, and weight change in patients receiving dose-intensive chemotherapy Oncology 8(4): 61
Sorbe, B.; Hallén, C. 1991: Betamethasone-dixyrazine versus betamethasone-metoclopramide as antiemetic treatment of cisplatin-doxorubicin-induced nausea in ovarian carcinoma patients European Journal of Gynaecological Oncology 12(1): 31-37
Locker, G.J.; Kofler, J.; Stoiser, B.; Wilfing, A.; Wenzel, C.; Wögerbauer, M.; Steger, G.G.; Zielinski, C.C.; Mader, R.; Burgmann, H. 2000: Relation of pro- and anti-inflammatory cytokines and the production of nitric oxide in patients receiving high-dose immunotherapy with interleukin-2 European Cytokine Network 11(3): 391-396
Hong, R.; Ma, F.; Shi, X.; Li, Q.; Zhang, P.; Yuan, P.; Wang, J.; Fan, Y.; Cai, R.; Li, Q.; Xu, B. 2014: Comparison of the effectiveness of platinum-based chemotherapy versus non-platinum-based chemotherapy for triple-negative breast cancer with metastases confined to the lungs Zhonghua Zhong Liu Za Zhi 36(10): 788-792